Description
CJC-1295 (no DAC) is a shortened synthetic analogue of growth hormone releasing hormone (Mod GRF 1-29) designed to stimulate the natural pulsatile release of growth hormone (GH), leading to increased levels of insulin-like growth factor 1 (IGF-1). Without the Drug Affinity Complex (DAC) modification, it has a shorter plasma half-life and is rapidly cleared, allowing for more controlled, physiologic GH signaling.
